1H-Indazole-3-carboxaldehyde, 4-hydroxy-
CAS No. 193683-28-2
Efalizumab
339155-58-7
Residues, silver-refining
97926-88-0
Procavia abyssinica, ext.
97926-83-5
3,5-Dibomo-4-Hydroxybenzaldehyde
297-77-5
2-BUTYNE-1,4-DIOL,99%
10-65-6
2-(2-phenylethenyl)benzo[c]phenanthrene
32829-04-2
4-Pentynal
18498-59-4
4-HYDROXY DARUNAVIR
313682-97-2
L-Noviose
107739-83-3
1-Undecene, 3-methyl-
18435-37-5
Benzenemethanol, 3-bromo-a-methyl-a-2-propenyl-
871089-69-9
benzyl 2-nitropropanoate
3017-54-7
N-(4-bromo-2-methyl-benzoyl)pyrrolidine
276678-35-4
Benzene, [(phenylsulfonyl)sulfonylmethyl]-
312613-12-0
ethenyl acetate - ethyl prop-2-enoate (1:1)
30174-69-7
OXIRANEACETIC ACID,3-VINYL-,TRANS-
184353-04-6
3-(3-Ethylthioureido)phenylboronic acid
1072946-06-5
4-chloro-2-[(2-chloroacetyl)amino]Benzoic acid
187942-05-8
5-Hexen-2-amine, N-butyl-N-chloro-
312631-33-7
Silane, (3,3-dimethylbutyl)triethyl-
105732-06-7
Org 42675
343776-67-0
1,6-Octadiene, 8-methoxy-2,7-dimethyl-
29777-77-3
N-Phenylacetylglutamine, 95%
184972-99-4
Reticuloendothelial system, ext.
97926-89-1